• About us
• Contact

Advertisement

Organisation › Details

Crown Bioscience Inc. (CrownBio)

Crown Bioscience, a JSR Life Sciences company, is a global CRO that provides preclinical and translational platforms to help our customers advance their research and development in oncology, immuno-oncology, and immune-mediated inflammatory diseases. We are the exclusive preclinical CRO to offer tumor organoid services with the well-established Hubrecht Organoid Technology. In addition, we have developed the largest commercially available PDX collection in the world. We focus on helping our customers develop novel therapies to maximize the chances that patients receive the right treatment at the right time. Founded in 2006, Crown Bioscience has 13 facilities across the United States, Europe, and Asia. *

 

	Start	2006-01-01 established
	Group	JSR Corporation (Group)
	Industry	drug discovery services
	Industry 2	contract research (drugs)
	Person	Spura, Armin (Crown Bioscience 202006 CEO at Crown Bioscience Inc)
	Person 2	Wery, Jean-Pierre (Crown Bioscience 201709 CEO)
	Street	3375 Scott Blvd. Suite 108
	City	95054 Santa Clara, CA
	Tel	+1-855-827-6968
		Address record changed: 2020-12-02
Basic data	Employees	n. a.
		* Document for »About Section«: Indivumed GmbH. (1/25/23). "Press Release: Crown Bioscience to Acquire Indivumed’s Service Business and Supporting Biobank". San Diego, CA & Hamburg.
		Record changed: 2023-11-15

Advertisement

More documents for JSR Corporation (Group)

• [1] KBI Biopharma, Inc.. (4/15/24). "Press Release: KBI Biopharma Appoints Jean-Baptiste Agnus as Chief Business Officer". Durham, NC....
• [2] Crown Bioscience, Inc.. (4/4/23). "Press Release: Crown Bioscience Announces Transaction Closing of Indivumed’s Service Business and Supporting Biobank". San Diego, CA....
• [3] Indivumed GmbH. (1/25/23). "Press Release: Crown Bioscience to Acquire Indivumed’s Service Business and Supporting Biobank". San Diego, CA & Hamburg....
• [4] Selexis S.A.. (5/2/22). "Press Release: JSR Appoints Veteran Biotech and CDMO Leader Mark W. Womack to Lead KBI Biopharma and Selexis SA". Sunnyvale, CA....
• [5] Selexis S.A.. (3/18/21). "Press Release: SpyBiotech Licenses Selexis Best-in-Class Cell Line Development Technologies to Advance Human Cytomegalovirus VLP Vaccine Program". Geneva....
• [6] Selexis S.A.. (10/20/20). "Press Release: JSR Life Sciences Expands Its European Gene-to-GMP Biologics Manufacturing Facilities for Selexis and KBI Biopharma in Geneva, Switzerland". Sunnyvale, CA....
• [7] Selexis S.A.. (10/16/20). "Press Release: Selexis Names Biopharmaceutical Executive Dirk Lange as New Chief Executive Officer". Geneva....
• [8] Selexis S.A.. (1/9/20). "Press Release: Selexis Promotes Dr. Yemi Onakunle to Chief Business Officer". Geneva....
• [9] Selexis S.A.. (6/20/19). "Press Release: Avacta and Selexis Partner to Develop Cell Line for Clinical Manufacturing". Cambridge & Geneva....
• [10] Selexis S.A.. (3/28/19). "Press Release: Selexis Bolsters Business Development Team to Support Expanding Base of Partners Relying on Its SUREtechnology to Advance Complex Biologics and Vaccines". Geneva....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.